Exelixis Inc. Common Stock vs VanEck Uranium & Nuclear ETF — how do they compare? Exelixis Inc. Common Stock trades at $60.1 (market cap $14.62B), while VanEck Uranium & Nuclear ETF trades at $103.08 (market cap $3.51B). The key difference: Exelixis Inc. Common Stock is far larger — about 4.2× VanEck Uranium & Nuclear ETF's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and VanEck Uranium & Nuclear ETF for 7 Days on average.
| EXEL | NLR | |
|---|---|---|
Market Cap | $14.62B | $3.51B |
Volume | 2,684,957 | 414,516 |
Sector | Health | Sector/Thematic |
52-Week High | $59.13 | $164.37 |
52-Week Low | $34.54 | $102.38 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $13.95B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →